Processing of GABABR1 in heterologous expression systems.
Novartis Pharma AG, Basel, Switzerland. Johannes.Mosbacher@pharma.novartis.com
J
J
Mosbacher
K
K
Kaupmann
V
V
Schuler
D
D
Ristig
K
K
Struckmeyer
T
T
Pfaff
A
A
Karschin
M F
MF
Pozza
B
B
Bettler
D000818:Animals; D002460:Cell Line; D003001:Cloning, Molecular; D019204:GTP-Binding Proteins / Q000378:metabolism*; D049452:Green Fluorescent Proteins; D006801:Humans; D007150:Immunohistochemistry; D008164:Luminescent Proteins; D015221:Potassium Channels / Q000378:metabolism; D051381:Rats; D018080:Receptors, GABA-B / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins
D008164:Luminescent Proteins; D015221:Potassium Channels; D018080:Receptors, GABA-B; D011993:Recombinant Fusion Proteins; D049452:Green Fluorescent Proteins; D019204:GTP-Binding Proteins